Sign in
CompletedNo phase

Mindfulness Intervention for Fibromyalgia Delivered Through a Smartphone App

Key facts

Who runs it
Brigham and Women's Hospital
Where
Boston, United StatesSee the site
Trial code
Status
Completed
People taking part
54 people enrolled
Started
3 May 2024
Ended
1 Aug 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Mindfulness Intervention
Record updated
29 January 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Adults aged 18 to 65
  • Diagnosis of fibromyalgia per Wolfe et al. (2011) criteria
  • Stable medication regimen or medication-free
  • Fluent in English
  • Able to provide informed consent

Who cannot take part

  • Comorbid pain condition more severe than fibromyalgia
  • Current psychosis or history of severe psychiatric illness
  • Any condition that may interfere with study compliance as judged by the PI or study coordinator
  • Pregnancy or breastfeeding
  • Active suicidal ideation
  • Participation in another therapeutic trial

Where in United States

  • The Brigham and Women's Hospital Department of AnesthesiologyBoston, United States

About the trial

What the trial wants to find out

The purpose of this pilot feasibility study is to evaluate the effects of a smartphone-based mindfulness intervention (MBI) on pain-related outcomes in individuals with fibromyalgia. This 8-week randomized controlled trial will compare an MBI app group to a control group who completes assessments only through the app.

Read full original descriptionShow less

The MBI intervention includes weekly video content focused on mindfulness practice and psychoeducation, combined with daily symptom tracking through the app. Participants in both groups will complete self-report measures at baseline, post-intervention, and follow-ups at 3 and 6 months.

The study will enroll up to 100 participants from Brigham and Women's Hospital and the greater Boston area. This pilot study is designed to assess feasibility and explore preliminary effects on outcomes such as pain interference, fibromyalgia symptoms, pain catastrophizing, sleep disturbance, emotional distress, mindfulness, and pain acceptance. Results will be used to inform the design of a future fully powered randomized trial.

The 2 groups in the trial

  • Mindfulness-Based Intervention (MBI)Treatment being tested

    Participants in this group will receive access to a smartphone app delivering an 8-week mindfulness-based intervention. The app includes weekly video modules (mindfulness practice and psychoeducation), daily pain tracking, and weekly assessments.

    Treatment: Mindfulness Intervention

  • ControlNo study treatment, for comparison

    Participants in this group will complete the same daily and weekly assessments via the smartphone app but will not have access to the mindfulness or psychoeducation content.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 January 2026